Medtech 360

December 2013

Chinese Markets for Peripheral Vascular Devices 2014

Introduction:

All segments of the Chinese market for PV devices will expand as rapid economic growth supports increasing treatment of the large and relatively undiagnosed patient population suffering from PVD.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in China across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   Aortic stent grafts comprise by far the largest segment of the Chinese PV device market.

What is driving increased usage of aortic stent grafts in China?

How does the usage of these products differ between China and the rest of the world?

  *   The Chinese PV device market is characterized by large regional disparities.

Where are the largest regional markets currently?

Where are the fastest-growing regional markets?

What cities and hospitals perform the most PV procedures?

  *   Endovascular procedures are becoming increasingly common for treating PVD in China.

In which indication is growth fastest?

How will negative clinical trials concerning the carotid and renal indications affect the Chinese market?

  *   Highly anticipated DES and DCB devices for the lower extremities will expand the treatable population and drive market growth.

When will DES and DCBs become available in this region and how quickly will they be adopted?

For which indications will DES and DCBs become most commonly used?

  *   The Chinese PV device market is dominated by large international manufacturers.

Who are the leading competitors in each of the PV device segments?

In which segments are domestic manufacturers challenging the positions of the international manufacturers, and how?

What competitive strategies can firms use to maintain and/or improve their competitive positions going forward?

Scope:

Geographies Covered: Millennium Research Group's analysis uses the following breakdown of regions in China:

Country

China

Region

PLMs

East Coast

Central

Other Regions

Notes: PLMs include Beijing, Shanghai, and Tianjin. East coast includes Fujian, Guangdong, Jiangsu, Shandong, and Zhejiang. Central includes Anhui, Hebei, Henan, Hubei, Hunan, Jiangxi, and Shanxi. other regions include Chongqing, Gansu, Guangxi, Guizhou, Hainan, Heilongjiang, Inner Mongolia, Jilin, Liaoning, Ningxia, Qinghai, Shaanxi, Sichuan, Tibet, Xinjiang, and Yunnan.

Procedures Covered: Millennium Research Group's analysis uses the following breakdown of procedures:

Technique

Endovascular

Scope

Interventional

Product Type

PV Stents and PTA Balloon Catheters

Procedure Type

POBA

PTA-with-Stent

Direct Stenting

Indication

Carotid

Renal

Iliac

Fem-Pop

Infrapop

AV Access

EPDs

IVCFs

Aortic Stent Grafts

Indication

Abdominal

Thoracic

Diagnostic-Only

Surgical

Procedure Type

Synthetic Surgical Graft Procedures

Indication

Abdominal Aortic

Thoracic Aortic

XA

AV Access

ATK PV Bypass

BTK PV Bypass

Products Covered: Millennium Research Group's analysis uses the following breakdown of products in the market:

Product Type

PV Stents

Indication

Carotid

Renal

Iliac

Fem-Pop

Infrapop

Product Type

SX

BX

Covered

Drug-Eluting

PTA Balloon Catheters

Indication

Carotid

Renal

Iliac

Fem-Pop

Infrapop

AV Access

Product Type

Small

Standard

Large

High-Pressure

Specialty

Drug-Coated

EPDs

IVCFs

Product Type

Retrievable

Permanent

Aortic Stent Grafts

Indication

Abdominal

Thoracic

Synthetic Surgical Grafts

Indication

Abdominal Aortic

Thoracic Aortic

XA

AV Access

ATK PV Bypass

BTK PV Bypass

Material

Polyester

ePTFE

PV Accessory Devices

Product Type

Guidewires

Diagnostic Catheters

Sheaths

Guiding Catheters

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Darren Lin

Contributors
Karen Gierszewski
Samuli Heilala, M.Sc.
Alice-Louise Madden, M.Sc.
Veronica Ross
Jackie Tang, M.A.



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • 480 Biomedical
  • Aastrom Biosciences
  • Abbott Laboratories
  • Abbott Vascular
  • ALN
  • AngioDynamics
  • Aptus Endosystems
  • Artegraft
  • Arteriocyte Medical Systems
  • ASAHI INTECC
  • Atrium Medical
  • Avinger
  • Bard Peripheral Vascular
  • Bayer HealthCare
  • B. Braun
  • BIOTRONIK
  • Bolton Medical
  • Boston Scientific
  • Cook Medical
  • Cordis
  • Covidien
  • C. R. Bard
  • CSI
  • Edwards Lifesciences
  • Endologix
  • Getinge Group
  • Hansen Medical
  • IDEV Technologies
  • Invatec
  • Kensey Nash
  • LeMaitre Vascular
  • Lifetech Scientific
  • Lombard Medical Technologies
  • Lutonix
  • MAQUET
  • MEDRAD
  • Medtronic
  • Merit Medical Systems
  • MicroPort Medical
  • NuMED
  • OptiMed
  • Pathway Medical Technologies
  • S&G Biotech
  • Spectranetics
  • St. Jude Medical
  • Taewoong Medical
  • Teleflex Medical
  • Terumo
  • TriVascular
  • Vascular Concepts
  • W. L. Gore
Decision Resources Group brands include: